Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms

Endothelial cell infection and endotheliitis in COVID-19

Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358

Neurologic features in severe SARS-CoV-2 infection

Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., Leacy, R. A. D., Shigematsu, T., Ladner, T. R., Yaeger, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,114

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

Moriguchi, T., Harii, N., Goto, J., Harada, D., Sugawara, H., Takamino, J., Ueno, M., Sakata, H., Kondo, K., Myose, N., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.062 · Cited by 2,024

Multiorgan and Renal Tropism of SARS-CoV-2

Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775

Frontal encephalopathy related to hyperinflammation in COVID-19

Cani, I., Barone, V., D’Angelo, R., Pisani, L., Allegri, V., Spinardi, L., Malpassi, P., Fasano, L., Rinaldi, R., Fanti, S., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10057-5 · Cited by 45

Guillain–Barré syndrome in the COVID-19 era: another occasional cluster?

Tatu, L., Nono, S., Grácio, S., & Koçer, S. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10005-3 · Cited by 32

SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids

Pellegrini, L., Albecka, A., Mallery, D. L., Kellner, M. J., Paul, D., Carter, A. P., James, L. C., & Lancaster, M. A. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.10.001 · Cited by 562

High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms

Franke, C., Ferse, C., Kreye, J., Reincke, S. M., Sánchez-Sendín, E., Rocco, A., Steinbrenner, M., Angermair, S., Treskatsch, S., Zickler, D., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.022 · Cited by 282

Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome

Komaroff, A. L., & Lipkin, W. I. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.06.002 · Cited by 276

Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms

Song, E., Bartley, C. M., Chow, R. D.-W., Ngo, T. T., Jiang, R., Zamecnik, C. R., Dandekar, R., Loudermilk, R. P., Dai, Y., Liu, F., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100288 · Cited by 219

COVID-19 vasculitis and novel vasculitis mimics

McGonagle, D., Bridgewood, C., Ramanan, A. V., Meaney, J. F. M., & Watad, A. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30420-3 · Cited by 192

Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid

Heming, M., Li, X., Räuber, S. J., Mausberg, A. K., Börsch, A., Hartlehnert, M., Singhal, A., Lu, I., Fleischer, M., Szepanowski, F., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.12.011 · Cited by 181

Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword

Tan, L. Y., Komarasamy, T. V., & Balasubramaniam, V. R. M. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742941 · Cited by 184

COVID-19 associated cognitive impairment: A systematic review

Tavares-Júnior, J. W. L., de Souza, A. C. C., Borges, J. W. P., Oliveira, D. N., Neto, J. I. S., Sobreira-Neto, M. A., & Braga‐Neto, P. (2022) · Cortex · doi:10.1016/j.cortex.2022.04.006 · Cited by 179

Cerebrospinal fluid in COVID-19: A systematic review of the literature

Lewis, A. K., Frontera, J. A., Placantonakis, D. G., Lighter, J., Galetta, S. L., Balcer, L. J., & Melmed, K. R. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117316 · Cited by 165

COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance

Achar, A., & Ghosh, C. (2020) · Cells · doi:10.3390/cells9112360 · Cited by 160

Neurological complications and infection mechanism of SARS-CoV-2

Wan, D., Du, T., Hong, W., Chen, L., Que, H., Lu, S., & Peng, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00818-7 · Cited by 140

The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models

Butowt, R., Meunier, N., Bryche, B., & von Bartheld, C. S. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02314-2 · Cited by 127

Neuropathology of COVID-19 (neuro-COVID): clinicopathological update

Lou, J. J., Movassaghi, M., Gordy, D. E., Olson, M. G., Zhang, T., Khurana, M. S., Chen, Z., Perez-Rosendahl, M. A., Thammachantha, S., Singer, E. J., et al. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2021-2993 · Cited by 120

Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study

Etter, M. M., Martins, T. A., Kulsvehagen, L., Pössnecker, E., Duchemin, W., Hogan, S. A., Sanabria-Díaz, G., Müller, J., Chiappini, A., Rychen, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34068-0 · Cited by 112

Cognitive decline following acute viral infections: literature review and projections for post-COVID-19

Damiano, R. F., Guedes, B. F., de Rocca, C. C., de Pádua Serafim, A., Castro, L. H. M., Munhoz, C. D., Nitrini, R., Filho, G. B., Miguel, E. C., Lucchetti, G., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01286-4 · Cited by 98

Acute and Post-Acute Neurological Complications of COVID-19

Al-Ramadan, A., Rabab’h, O., Shah, J., & Gharaibeh, A. (2021) · Neurology International · doi:10.3390/neurolint13010010 · Cited by 98

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID ‐19

Apple, A. C., Oddi, A., Peluso, M. J., Asken, B. M., Henrich, T. J., Kelly, J. D., Pleasure, S. J., Deeks, S. G., Allen, I. E., Martin, J. N., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51498 · Cited by 87

COVID ‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era

Taga, A., & Lauria, G. (2022) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12482 · Cited by 86

Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses

Rabaan, A. A., Al-Ahmed, S. H., Garout, M. A., Al‐Qaaneh, A. M., Sule, A. A., Tirupathi, R., Mutair, A. S. A., Alhumaid, S., Hasan, A., Dhawan, M. K., et al. (2021) · Pathogens · doi:10.3390/pathogens10050565 · Cited by 84

Neuropsychiatric complications of covid-19

Butler, M., Pollak, T. A., Rooney, A. G., Michael, B. D., & Nicholson, T. R. (2020) · BMJ · doi:10.1136/bmj.m3871 · Cited by 85

Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms

Johansson, A., Mohamed, M. S., Moulin, T. C., & Schiöth, H. B. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577658 · Cited by 80

Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm

Garcia, M. A., Barreras, P., Lewis, A., Pinilla-Monsalve, G. D., Sokoll, L. J., Kickler, T. S., Mostafa, H. H., Caturegli, M., Moghekar, A., Fitzgerald, K. C., et al. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117517 · Cited by 81

Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients

Remsik, J., Wilcox, J. A., Babady, N. E., McMillen, T. A., Vachha, B. A., Halpern, N. A., Dhawan, V., Rosenblum, M., Iacobuzio-Donahue, C. A., Avila, E. K., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.007 · Cited by 77

Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients

Ermis, U., Rust, M. I., Bungenberg, J., Costa, A. S., Dreher, M., Balfanz, P., Marx, G., Wiesmann, M., Reetz, K., Tauber, S. C., et al. (2021) · Neurological Research and Practice · doi:10.1186/s42466-021-00116-1 · Cited by 77

Status epilepticus and COVID-19: A systematic review

Dono, F., Nucera, B., Lanzone, J., Evangelista, G., Rinaldi, F., Speranza, R., Troisi, S., Tinti, L., Russo, M., Pietro, M. D., et al. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.107887 · Cited by 67

Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients

Lersy, F., Benotmane, I., Helms, J., Collange, O., Schenck, M., Brisset, J., Chammas, A., Willaume, T., Lefèbvre, N., Solis, M., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa745 · Cited by 61

Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms

Edén, A., Grahn, A., Bremell, D., Aghvanyan, A., Bathala, P., Fuchs, D., Gostner, J. M., Hagberg, L., Kanberg, N., Kanjananimmanont, S., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.13253 · Cited by 61

Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry

García‐Azorín, D., Abildúa, M. J. A., Aguirre, M. E. E., Fernández, S. F., Moncó, J. C. G., Guijarro-Castro, C., González-Platas, M., Delgado, F. R., Andrés, J. M. L., Ezpeleta, D., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117283 · Cited by 56

Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient

Nuzzo, D., Cambula, G., Bacile, I., Rizzo, M., Galia, M., Mangiapane, P., Picone, P., Giacomazza, D., & Scalisi, L. (2021) · Brain Sciences · doi:10.3390/brainsci11040454 · Cited by 50

MOG-associated encephalitis following SARS-COV-2 infection

Peters, J., Alhasan, S., Vogels, C. B. F., Grubaugh, N. D., Farhadian, S., & Longbrake, E. E. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102857 · Cited by 49

What SARS-CoV-2 does to our brains

Aschman, T., Mothes, R., Heppner, F. L., & Radbruch, H. (2022) · Immunity · doi:10.1016/j.immuni.2022.06.013 · Cited by 50

Cerebral vasculitis of medium-sized vessels as a possible mechanism of brain damage in COVID-19 patients

Lersy, F., Anheim, M., Willaume, T., Chammas, A., Brisset, J., Cotton, F., & Kremer, S. (2020) · Journal of Neuroradiology · doi:10.1016/j.neurad.2020.11.004 · Cited by 47

Neurological disorders after severe pneumonia are associated with translocation of endogenous bacteria from the lung to the brain

Ma, Q., Yao, C., Wu, Y., Wang, H., Fan, Q., Yang, Q., Xu, J., Dai, H., Zhang, Y., Xu, F., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi0699 · Cited by 45

Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature

Stoian, A., Stoian, M., Bajkó, Z., Maier, S., Andone, S. R., Cioflinc, R. A., Moțățăianu, A., Bărcuţean, L., & Bălașa, R. (2022) · Biomedicines · doi:10.3390/biomedicines10040774 · Cited by 42

The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation

Reinhold, D., Farztdinov, V. M., Yan, Y., Meisel, C., Sadlowski, H., Kühn, J., Perschel, F. H., Endres, M., Düzel, E., Vielhaber, S., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02711-2 · Cited by 44

Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic

de Andrade, E. G., Šimončičová, E., Carrier, M., Vecchiarelli, H. A., Robert, M.-È., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.647378 · Cited by 39

COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection

Straburzyński, M., Nowaczewska, M., Budrewicz, S. P., & Waliszewska‐Prosół, M. (2021) · Cephalalgia · doi:10.1177/03331024211040753 · Cited by 39

Provoked seizures and status epilepticus in a pediatric population with COVID‐19 disease

Thongsing, A., Eizadkhah, D., Fields, C., & Ballaban‐Gil, K. R. (2022) · Epilepsia · doi:10.1111/epi.17293 · Cited by 37

Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models

Bauer, L., Lendemeijer, B., Leijten, L. M. E., Embregts, C. W. E., Rockx, B., Kushner, S. A., de Vrij, F. M. S., & van Riel, D. A. J. (2021) · mSphere · doi:10.1128/msphere.00270-21 · Cited by 34

SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t

Lingor, P., Demleitner, A. F., Wolff, A. W., & Feneberg, E. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02500-w · Cited by 37

Herpesvirus and neurological manifestations in patients with severe coronavirus disease

Carneiro, V. C. D. S., Alves‐Leon, S. V., Sarmento, D. J. D. S., Coelho, W. L. D. C. N. P., Moreira, O. C., Salvio, A. L., Ramos, C. H. F., Filho, C. H. F. R., Marques, C. A. B., Gonçalves, J. P. D. C., et al. (2022) · Virology Journal · doi:10.1186/s12985-022-01828-9 · Cited by 33

Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19

Tizenberg, B., Brenner, L. A., Lowry, C. A., Okusaga, O. O., Benavides, D. R., Hoisington, A. J., Benros, M. E., Stiller, J. W., Kessler, R. C., & Postolache, T. T. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01275-3 · Cited by 33

MOG antibody-associated encephalitis secondary to Covid-19: case report

Durovic, E., Bien, C., Bien, C. G., & Isenmann, S. (2021) · BMC Neurology · doi:10.1186/s12883-021-02449-5 · Cited by 32

Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer’s disease

Chen, J., Chen, J., Lei, Z., Zhang, F., Zeng, L., Wu, X., Li, S., & Tan, J. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02692-z · Cited by 33

What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS‐CoV‐2

Li, Y., Zhang, Y., & Tan, B. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26943 · Cited by 31

SARS-CoV-2 airway infection results in the development of somatosensory abnormalities in a hamster model

Serafini, R. A., Frere, J. J., Zimering, J. H., Giosan, I. M., Pryce, K. D., Golynker, I., Panis, M., Ruiz, A., tenOever, B. R., & Zachariou, V. (2023) · Science Signaling · doi:10.1126/scisignal.ade4984 · Cited by 29

Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis

Edén, A., Simrén, J., Price, R. W., Zetterberg, H., & Gisslén, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15459 · Cited by 29

Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19

Adesse, D., Gladulich, L., Alvarez-Rosa, L., Siqueira, M., Marcos, A. C., Heider, M., Motta, C. S., Torices, S., Toborek, M. J., & Stipursky, J. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00357-5 · Cited by 30

Cerebrospinal fluid findings in COVID-19 indicate autoimmunity

Lucchese, G. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30147-6 · Cited by 29

Potential role of astrocyte angiotensin converting enzyme 2 in the neural transmission of COVID-19 and a neuroinflammatory state induced by smoking and vaping

Zhang, Y., Archie, S. R., Ghanwatkar, Y., Sharma, S., Nozohouri, S., Burks, E., Mdzinarishvili, A., Liu, Z., & Abbruscato, T. J. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00339-7 · Cited by 29

COVID-19 im Alter – Die geriatrische Perspektive

Wirth, R., Becker, C., Djukic, M., Drebenstedt, C., Heppner, H. J., Jacobs, A. H., Meisel, M., Michels, G., Nau, R., Pantel, J., et al. (2021) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-021-01864-0 · Cited by 30

Clinical, cerebrospinal fluid and neuroimaging findings in COVID-19 encephalopathy: a case series

Tuma, R., Guedes, B., Carra, R., Iepsen, B., Rodrigues, J., Camelo-Filho, A. E., Kubota, G., Ferrari, M., Neto, A. S., Oku, M. H. M., et al. (2020) · doi:10.1101/2020.08.28.20181883 · Cited by 26

Neuroinvasive potential of SARS‐CoV2 with neuroradiological and neuropathological findings: is the brain a target or a victim?

Franca, R. A., Ugga, L., Guadagno, E., Russo, D., & De, M. D. B. (2020) · Apmis · doi:10.1111/apm.13092 · Cited by 26

Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism

Leta, V., Boura, I., van Wamelen, D. J., Rodríguez‐Violante, M., Antonini, A., & Chaudhuri, К. R. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.04.004 · Cited by 26

Histopathological Findings in COVID-19 Cases: A Systematic Review

Hammoud, H., Bendari, A., Bendari, T., & Bougmiza, I. M. (2022) · Cureus · doi:10.7759/cureus.25573 · Cited by 27

Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review

Feizi, P., Sharma, K., Pasham, S. R., Nirwan, L., Joseph, J. T., Jaiswal, S., & Sriwastava, S. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577939 · Cited by 25

Brain Organoids: Studying Human Brain Development and Diseases in a Dish

Xu, J., & Wen, Z. (2021) · Stem Cells International · doi:10.1155/2021/5902824 · Cited by 25

Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far

Boura, I., & Chaudhuri, К. R. (2022) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13461 · Cited by 26

Consensus Clinical Guidance for Diagnosis and Management of Adult COVID-19 Encephalopathy Patients

Michael, B. D., Walton, D., Westenberg, E., García‐Azorín, D., Singh, B., Tamborska, A., Netravathi, M., Chomba, M., Wood, G. K., Easton, A., et al. (2021) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.22010002 · Cited by 26

Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review

Domingues, R. B., Leite, F. B. V. D. M., & Senne, C. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 21

Review of Neurological Manifestations of SARS-CoV-2

Priyal, P., Sehgal, V., Kapila, S., Taneja, R., Mehmi, P., & Gulati, N. (2023) · Cureus · doi:10.7759/cureus.38194 · Cited by 20

Myoclonus and COVID‐19 : A Challenge for the Present, a Lesson for the Future

Latorre, A., & Rothwell, J. C. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13103 · Cited by 20

Neuropathogenesis of acute coronavirus disease 2019

Farhadian, S., Seilhean, D., & Spudich, S. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000944 · Cited by 20

Cerebrospinal Analysis in Patients With COVID-19

Miller, E. H., Namale, V. S., Kim, C. F., Dugue, R., Waldrop, G. E., Ciryam, P., Chong, A. M., Zucker, J. E., Miller, E. C., Bain, J., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa501 · Cited by 18

Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review

Domingues, R. B., Leite, F. B. V. D. M., & Senne, C. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2021-0117 · Cited by 19

Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis

Schweitzer, F., Kleineberg, N. N., Göreci, Y., Onur, O. A., Franke, C., & Warnke, C. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000930 · Cited by 18

Neurologic manifestations of COVID-19 in critically ill patients: results of the prospective multicenter registry PANDEMIC

Dimitriadis, K. A., Meis, J., Neugebauer, H., Barlinn, K., Neumann, B. H., Gahn, G., Lochner, P., Knier, B., Lindemann, S., Sühs, K., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04080-3 · Cited by 17

Case Report: Identification of SARS-CoV-2 in Cerebrospinal Fluid by Ultrahigh-Depth Sequencing in a Patient With Coronavirus Disease 2019 and Neurological Dysfunction

Xiang, P., Xu, X., Lü, X., Gao, L., Wang, H., Li, Z., Xiong, H., Li, R., Xiong, Y., Pu, L., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.629828 · Cited by 15

Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?

on behalf of the “Cognitive and Behavioral Neurology” Study Group of the Italian Neurological Society, Stracciari, A., Bottini, G., Guarino, M., Magni, E., & Pantoni, L. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05231-0 · Cited by 20

Clinical Implications of COVID-19 Presence in CSF: Systematic Review of Case Reports

Elmakaty, I., Ferih, K., Karen, O., Ouda, A., Elsabagh, A. A., Amarah, A., & Malki, M. I. (2022) · Cells · doi:10.3390/cells11203212 · Cited by 16

Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report

Bozzali, M., Grassini, A., Morana, G., Zotta, M., Cabras, S., Romagnolo, A., Artusi, C. A., Montalenti, E., Rizzone, M. G., Garbossa, D., et al. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05233-y · Cited by 14

Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19

Paris, G. C., de Azevedo, A., Ferreira, A. L. P., Azevedo, Y. M. A. D., Rainho, M. D. A., de Oliveira, G. P., Silva, K. R., Cortez, E. A. C., Stumbo, A. C., de Carvalho, S. N., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119510 · Cited by 15

78-year-old woman with opsoclonus myoclonus ataxia syndrome secondary to COVID-19

Saha, B. K., Saha, S., & Chong, W. H. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-243165 · Cited by 15

SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study

Nersesjan, V., Amiri, M., Nilsson, A. C., Wamberg, C., Jensen, V. V. S., Petersen, C. B., Hejl, A., Lebech, A., Theut, A. M., Jørgensen, C. S., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad274 · Cited by 15

Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia?

Lima, M., Aloizou, A., Siokas, V., Bakirtzis, C., Liampas, I., Tsouris, Z., Bogdanos, D. P., Balogiannis, S., & Dardiotis, E. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0148 · Cited by 34

Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients

Ramezani, S., Ezzatifar, F., Hojjatipour, T., Hemmatzadeh, M., Shabgah, A. G., Navashenaq, J. G., Aslani, S., Shomali, N., Arabi, M., Babaie, F., et al. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07907-y · Cited by 14

S1-Leitlinie: Neurologische Manifestationen bei COVID-19

Berlit, P. (2020) · DGNeurologie · doi:10.1007/s42451-020-00254-x · Cited by 14

Past to Present, Epidemiology of SARS-CoV-2 Infection and Ways of Treatment: A Review

Uluçay, O., Altunkülah, E., & Alkaşi, Ü. (2022) · Kafkas Journal of Medical Sciences · doi:10.5505/kjms.2022.90757 · Cited by 12

COVID-19 Post-Infectious Encephalitis Presenting With Delirium as an Initial Manifestation

Hara, M., Kouda, K., Mizoguchi, T., Yokota, Y., Hayashi, K., Gon, Y., & Nakajima, H. (2021) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096211029787 · Cited by 12

Inflammatory leptomeningeal cytokines mediate delayed COVID-19 encephalopathyPreprint

Remšík, J., Wilcox, J. A., Babady, N. E., McMillen, T. A., Vachha, B. A., Halpern, N. A., Dhawan, V., Rosenblum, M. K., Iacobuzio–Donahue, C. A., Avila, E. K., et al. (2020) · medRxiv · doi:10.1101/2020.09.15.20195511 · Cited by 12

Intrinsic factors behind long‐COVID: II. SARS‐CoV‐2, extracellular vesicles, and neurological disorders

El‐Maradny, Y. A., Rubio‐Casillas, A., Mohamed, K. I., Uversky, V. N., & Redwan, E. M. M. M. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30486 · Cited by 10

SARS-Cov-2 Replication in a Blood–Brain Barrier Model Established with Human Brain Microvascular Endothelial Cells Induces Permeability and Disables ACE2-Dependent Regulation of Bradykinin B1 Receptor

Coelho, S. V. A., Souza, G. L. E., Bezerra, B. B., Lima, L. R., Corrêa, I. A., de Almeida, D. V., Silva-Aguiar, R. P., Pinheiro, A. A. S., Sirois, P., Caruso‐Neves, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125540 · Cited by 11

Brain Renin–Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS‐CoV‐2

Ahmadi, S., & Khaledi, S. (2023) · Analytical Cellular Pathology · doi:10.1155/2023/8883492 · Cited by 12

Post-COVID parkinsonism: A scoping review

Polverino, P., Cocco, A., & Albanese, A. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.106066 · Cited by 11

Neuroinflammation and Oxidative Stress in Parkinson’s Disease, Alzheimer’s Disease, and COVID-19: Microglia–Neutrophil Interaction

de Araújo, A. B., Azul, F. V. C. S., Carneiro, Y. C., de Sousa, C. N. S., Vasconcelos, S. M. M., Rios, F. J. O., & Leal, L. K. A. M. (2026) · ACS Omega · doi:10.1021/acsomega.5c10397 · Cited by 9

A Systematic Review on Neurological Aspects of COVID-19: Exploring the Relationship Between COVID-19-Related Olfactory Dysfunction and Neuroinvasion

Purja, S., Oh, S., & Kim, E. Y. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.887164 · Cited by 10

Neurological manifestations of COVID-19: with emphasis on Iranian patients

Aslan, C., Nikfarjam, S., Asadzadeh, M., & Jafari, R. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00964-2 · Cited by 9

Myelin‐oligodendrocyte glycoprotein antibody‐associated optic neuritis following SARS‐CoV ‐2 pneumonia: A case report

Mitarnun, W., Naksanguan, T., Laoharattanahirun, N., Roekrat, P., Kimavaha, S., & Kajornrith, W. (2022) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12595 · Cited by 8

Insights into organoid-based modeling of COVID-19 pathology

Boroojerdi, M. H., Jabry, T. A., Mirarefin, S. M. J., & Albalushi, H. M. A. (2023) · Virology Journal · doi:10.1186/s12985-023-01996-2 · Cited by 10

The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis—A Literature Review

Kulikowska, J., Kulczyńska‐Przybik, A., Mroczko, B., & Kułakowska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115894 · Cited by 7

Neuroimaging in the First 6 Weeks of the COVID-19 Pandemic in an 8-Hospital Campus: Observations and Patterns in the Brain, Head and Neck, and Spine

Kelsch, R. D., Silbergleit, R., & Krishnan, A. S. (2021) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001179 · Cited by 7

COVID-19 encephalopathy: an unusual presentation with new-onset seizure causing convulsive status epilepticus

Siddiqui, A. F., Saadia, S., Ejaz, T., & Mushtaq, Z. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-245387 · Cited by 7

Association Between COVID-19 and Neurological Diseases: Evidence from Large-Scale Mendelian Randomization Analysis and Single-Cell RNA Sequencing Analysis

Huang, L., Wang, Y., He, Y., Huang, D., Wen, T., & Han, Z. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03975-2 · Cited by 6

Autoantigens of Small Nerve Fibers and Human Coronavirus Antigens: Is There a Possibility for Molecular Mimicry?

Gavrilova, N. Y., Normatov, M. G., Сопрун, Л. А., Utekhin, V. J., Fedotkina, T. V., & Churilov, L. P. (2024) · Current Microbiology · doi:10.1007/s00284-024-03885-5 · Cited by 6

Pseudotumor Cerebri Complicating Multisystem Inflammatory Syndrome in a Child

Divya, K., Chellappan, I., Kanagaraju, V., & Sundaram, P. (2021) · Journal of Current Ophthalmology · doi:10.4103/joco.joco_241_20 · Cited by 6

New-Onset Movement Disorders in COVID-19: Much Ado about Nothing?

Nirenberg, M. J. (2021) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.644 · Cited by 6

Current clinical findings of acute neurological syndromes after SARS‐CoV‐2 infection

Wang, M., Wang, J., Ren, Y. D., Lu, L., Xiong, W., Li, L., Xu, L., Tang, M., Yuan, Y., Xie, Y., et al. (2024) · MedComm · doi:10.1002/mco2.508 · Cited by 4

Dopamine and its precursor levodopa inactivate SARS-CoV-2 main protease by forming a quinoprotein

Hao, M., He, Y., Song, T., Guo, H., Rayman, M. P., & Zhang, J. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.05.008 · Cited by 5

Cerebrospinal fluid analysis of pregnant women at early stages of COVID-19

Sasaki, L. M. P., Fernandes, G. M., da Silva, Â. P., Motta, F., de Siracusa, C. C., Rabelo, I. P., dos Santos, A., França, P. S., Kurizky, P. S., Tristão, R. M., et al. (2022) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2022.03.043 · Cited by 5

Recommendation: Treatment of clinical long COVID encephalopathies with nasal administered mesenchymal stromal cell extracellular vesicles

Askenase, P. W. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2022.987117 · Cited by 5

SARS-CoV-2 RNA detection in cerebrospinal fluid: Presentation of two cases and review of literature

Luis, M. B., Liguori, N. F., López, P. A., & Alonso, R. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100282 · Cited by 17

Neurological Complications in COVID-19 Patients: Can Analysis of Specific Antibodies and Viral RNA in Paired Cerebrospinal Fluid and Serum be Used for Accurate Diagnosis of SARS-CoV-2 Neuroinflammatory Disease? A Case Series

Lauridsen, K. H., Olsen, K. B., Lund, E. L., Jensen, T. Ø., Pedersen, T. I., Harboe, Z. B., Antsupova, V. S., Rasmussen, L. D., Röser, D., Banner, J., et al. (2022) · Clinical Pathology · doi:10.1177/2632010x221139096 · Cited by 2

Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid

Espíndola, O. D. M., Siqueira, M. M., Soares, C., Lima, M. A., Leite, A. C. C. B., Araújo, A., Brandão, C. O., & Silva, M. T. T. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.123 · Cited by 85

CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms

Edén, A., Kanberg, N., Gostner, J. M., Fuchs, D., Hagberg, L., Andersson, L., Lindh, M., Price, R. W., Zetterberg, H., & Gisslén, M. (2020) · Neurology · doi:10.1212/wnl.0000000000010977 · Cited by 147

NEUROLOGICAL IMPACT OF COVID-19 PANDEMIC: LESSONS & CAUTIONS

Dutta, D. (2020) · Royal Book Publishing · doi:10.26524/royal.37.5 · Cited by 6